Here’s what you need to know.
1. Researchers from the Harvard T.H. Chan School of Public Health in Boston analyzed data from 68,466 women and 27,934 men in their late 60s. They were first assessed in 2002 and followed until 2010.
2. Of the group, 13 percent were regular users of the supplement. Through the use of the supplement they lowered their risk of developing colon cancer.
3. The researchers speculate the anti-inflammatory properties of the supplements reduce the risk.
More articles on gastroenterology/endoscopy:
Inflammatory bowel disease 3 times more common than previous estimates: 5 takeaways
Prix Galien USA Award names Cologuard this year’s ‘best medical technology product’: 3 notes
GI leader to know: Dr. Karel Rybnicek of Cleveland Gastroenterology Associates
